Capricor Therapeutics
CAPR
CAPR
20 hedge funds and large institutions have $2.57M invested in Capricor Therapeutics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$58K | |
| 2 | +$53.3K | |
| 3 | +$38.9K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$38K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.83K |
Top Sellers
| 1 | -$230K | |
| 2 | -$93K | |
| 3 | -$67.3K | |
| 4 |
Morgan Stanley
New York
|
-$6.67K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |